{
  "docId": "019de070-cb6f-702e-8ba7-38c2ee57750d",
  "docSlug": "70846fe5de6d20355c3868d80f4845b0",
  "documentTitle": "BioNTech | Results Presentation Deck | 36 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 36,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-cb6f-702e-8ba7-38c2ee57750d/7",
  "deckHref": "/decks/019de070-cb6f-702e-8ba7-38c2ee57750d",
  "deckJsonHref": "/decks/019de070-cb6f-702e-8ba7-38c2ee57750d.json",
  "deckAnchorHref": "/decks/019de070-cb6f-702e-8ba7-38c2ee57750d#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.42,
        "x": 0.06,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "Drug development can be faster: While COVID-19 was an extraordinary case, we intend to apply the capabilities we have developed during “Project Lightspeed” to rapidly advance other innovative medicines to the market.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "365795a5-5ff5-4169-959c-a8260c77164d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.42,
        "x": 0.06,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Our mRNA technology has the potential to address major global health challenges: The success of “first-generation” mRNA vaccines against COVID-19 highlights their future promise – we expect rapid iterations to further improve this new class of products.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f8bf25d-4c5b-48e6-8db8-3f496422d620",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.42,
        "x": 0.52,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "Our model is powerful: Our deep focus on innovation, coupled with powerful blue chip collaborators, gives us the ability to establish market-leading positions while building our own capabilities alongside our partners over the long-term.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "933b0527-2d3e-485d-9b79-90bcc1251515",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.42,
        "x": 0.52,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "BioNTech is well-placed to lead at the intersection of mRNA and immunology: We own a vast IP portfolio and have more than a decade of accumulated know-how in the field.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9be4c332-2724-4f86-8cf0-06f06bb01ba7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "What 2020 has demonstrated to us",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "561ab136-c822-40ff-8651-caa72fcc9395",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "ea16b6bf-4fff-47c2-ac41-4f78876cafc0",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Key Takeaways",
      "beatSlug": null,
      "evidence": "The document highlights BioNTech's capabilities and progress in 2020",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}